Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Specializing in the discovery and development of small molecule drugs, Cyclacel targets key biological pathways involved in cancer cell cycle regulation and DNA damage response. The company’s pipeline includes investigational treatments designed to address unmet medical needs in hematological malignancies and solid tumors. By leveraging advanced scientific research and a commitment to improving patient outcomes, Cyclacel Pharmaceuticals aims to deliver novel oncology solutions. The company collaborates with leading research institutions and maintains a robust portfolio of proprietary compounds, positioning itself at the forefront of cancer drug development.
